NGeneBio Co., Ltd.

307, 288 Digital-ro, Guro-gu, Seoul, 08390, Republic of Korea
Seoul,  08390

Korea (South)
http://ngenebio.com

NGeneBio was founded in 2015 as a spin-off venture from Korea Telecom, develops in vitro diagnostics (IVD)/companion diagnostics (CDx) products and bioinformatics SW with cutting-of-edge technologies including next generation sequencing (NGS). The company launched NGS-based breast/ovarian cancer panel (BRCAaccuTest) with clinical analysis SW (NGeneAnalySys) and received CE-IVD and KFDA approval in 2017. Currently launched NGS panels and SW for solid tumor and hematological malignancies.